WuXi AppTec Past Earnings Performance
Past criteria checks 2/6
WuXi AppTec has been growing earnings at an average annual rate of 30.8%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 25.4% per year. WuXi AppTec's return on equity is 14.7%, and it has net margins of 20.9%.
Key information
30.8%
Earnings growth rate
29.8%
EPS growth rate
| Life Sciences Industry Growth | 26.8% |
| Revenue growth rate | 25.4% |
| Return on equity | 14.7% |
| Net Margin | 20.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How WuXi AppTec makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 38,501 | 8,063 | 3,763 | 1,369 |
| 30 Jun 24 | 38,710 | 8,533 | 3,745 | 1,410 |
| 31 Mar 24 | 39,359 | 9,381 | 3,764 | 1,390 |
| 31 Dec 23 | 40,341 | 9,607 | 3,821 | 1,441 |
| 30 Sep 23 | 40,502 | 9,512 | 3,617 | 1,550 |
| 30 Jun 23 | 40,470 | 9,491 | 3,718 | 1,624 |
| 31 Mar 23 | 39,844 | 9,339 | 3,695 | 1,691 |
| 31 Dec 22 | 39,355 | 8,814 | 3,674 | 1,614 |
| 30 Sep 22 | 34,776 | 8,913 | 3,595 | 1,387 |
| 30 Jun 22 | 30,122 | 7,058 | 3,269 | 1,195 |
| 31 Mar 22 | 26,426 | 5,240 | 3,097 | 1,018 |
| 31 Dec 21 | 22,902 | 5,097 | 2,934 | 942 |
| 30 Sep 21 | 21,242 | 4,154 | 2,739 | 862 |
| 30 Jun 21 | 19,841 | 3,918 | 2,691 | 764 |
| 31 Mar 21 | 18,298 | 4,157 | 2,610 | 772 |
| 31 Dec 20 | 16,535 | 2,960 | 2,440 | 693 |
| 30 Sep 20 | 15,408 | 2,454 | 2,339 | 651 |
| 30 Jun 20 | 14,209 | 2,512 | 2,195 | 680 |
| 31 Mar 20 | 13,290 | 1,768 | 2,042 | 605 |
| 31 Dec 19 | 12,872 | 1,851 | 1,964 | 590 |
| 30 Sep 19 | 11,971 | 2,097 | 1,836 | 554 |
| 30 Jun 19 | 11,099 | 2,045 | 1,771 | 503 |
| 31 Mar 19 | 10,241 | 2,356 | 1,614 | 479 |
| 31 Dec 18 | 9,614 | 2,261 | 1,485 | 437 |
| 30 Sep 18 | 9,009 | 2,092 | 1,379 | 376 |
| 30 Jun 18 | 8,509 | 1,757 | 1,178 | 483 |
| 31 Mar 18 | 8,139 | 1,181 | 1,210 | 375 |
| 31 Dec 17 | 7,765 | 1,227 | 1,269 | 306 |
| 31 Dec 16 | 6,116 | 975 | 1,240 | 0 |
| 31 Dec 15 | 4,883 | 349 | 1,179 | 0 |
| 31 Dec 14 | 4,140 | 462 | 835 | 0 |
Quality Earnings: WX8 has high quality earnings.
Growing Profit Margin: WX8's current net profit margins (20.9%) are lower than last year (23.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: WX8's earnings have grown significantly by 30.8% per year over the past 5 years.
Accelerating Growth: WX8's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: WX8 had negative earnings growth (-15.2%) over the past year, making it difficult to compare to the Life Sciences industry average (5.4%).
Return on Equity
High ROE: WX8's Return on Equity (14.7%) is considered low.